–
Viridian Therapeutics, Inc.\DE
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−79.7
FY22:
−134
FY23:
−254
FY24:
−299
FY25:
−363
(positive)
Change from FY21 to FY25
millions USD
FY21:
−79.3
FY22:
−129
FY23:
−235
FY24:
−266
FY25:
−337
(positive)
Change from FY21 to FY25
millions USD
FY21:
−79.4
FY22:
−130
FY23:
−238
FY24:
−270
FY25:
−343
(positive)
Change from FY21 to FY25
millions USD
FY21:
−79.4
FY22:
−130
FY23:
−238
FY24:
−270
FY25:
−343
All amounts in millions USD